Opening and Keynote #1 - Health and economic benefits of tobacco harm reduction
- What does the current evidence tell us about the potential health and economic benefits of safer nicotine products?
- How should we weight this evidence?
- What more do we need to know, what is the prognosis for the future and what are the short and long-term costs of different policy alternatives?
- How might legislators and regulators balance health and economic imperatives to achieve positive outcomes?
- What factors might make for an effective legislative and regulatory framework?
- How should future progress be monitored, and policies adjusted in response?
Host
Grzegorz Król
![Grzegorz Król]( /media/images/GK-2019-200x217.2e16d0ba.fill-92x92.jpg )
Speaker
Andrzej Fal
![Andrzej Fal]( /media/images/fal-andrzej.2e16d0ba.fill-92x92.jpg )
Respondent
Michelle Minton
![Michelle Minton]( /media/images/minton-michelle-3.2e16d0ba.fill-92x92.jpg )